Adma Biologics (ADMA) Cash from Operations (QoQ) (2011 - 2025)
Adma Biologics (ADMA) Cash from Operations (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 168.10% |
| Sep 30, 2025 | -37.12% |
| Jun 30, 2025 | 207.44% |
| Mar 31, 2025 | -139.18% |
| Dec 31, 2024 | 100.64% |
| Sep 30, 2024 | -45.17% |
| Jun 30, 2024 | 2,157.98% |
| Mar 31, 2024 | -112.60% |
| Dec 31, 2023 | 46.83% |
| Sep 30, 2023 | 297.80% |
| Jun 30, 2023 | 58.85% |
| Mar 31, 2023 | -99.52% |
| Dec 31, 2022 | 44.45% |
| Sep 30, 2022 | -3.54% |
| Jun 30, 2022 | 50.68% |
| Mar 31, 2022 | 22.27% |
| Dec 31, 2021 | -149.51% |
| Sep 30, 2021 | 58.43% |
| Jun 30, 2021 | 2.91% |
| Mar 31, 2021 | -3.13% |